Advertisement

Topics

Latest "Apical Pharmaceutical Corporation" News Stories

03:36 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "Apical Pharmaceutical Corporation" found in our extensive news archives from over 250 global news sources.

More Information about Apical Pharmaceutical Corporation on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Apical Pharmaceutical Corporation for you to read. Along with our medical data and news we also list Apical Pharmaceutical Corporation Clinical Trials, which are updated daily. BioPortfolio also has a large database of Apical Pharmaceutical Corporation Companies for you to search.

Showing "Apical Pharmaceutical Corporation" News Articles 1–25 of 9,300+

Wednesday 12th December 2018

NDA Partners Expert Consultant Vinod Shah, PhD, Receives AAPS Award for Global Leadership

NDA Partners Chief Executive Officer Earle Martin announced today that Dr. Vinod Shah, one of the firm’s prominent Expert Consultants, was recently honored by the American Association of Pharmaceutical Scientists (AAPS) with the Global Leader Award for his significant research contributions to the pharmaceutical sciences field working in regulatory, standards-setting, and academic communities wo...


Humanwell Healthcare Group Co Ltd 600079 Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryHumanwell Healthcare Group Co Ltd Humanwell, formerly Wuhan Humanwell HiTech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anesthetics, biological products, herbal medicines, CNS medicines, women's health, antiinfection drugs, medical...

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018

Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of healthy human skin in different body sites Findings support application of epicutaneous immunotherapy (EPIT) to int


Santhera Announces Financial Results for the First Nine Months of 2018

Santhera Pharmaceuticals Holding AG / Santhera Announces Financial Results for the First Nine Months of 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and...

Santhera Launches Placement of Shares through Accelerated Bookbuilding

Santhera Pharmaceuticals Holding AG / Santhera Launches Placement of Shares through Accelerated Bookbuilding . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5...

Acacia Pharma Group plc: Acacia Pharma announces positive clinical results for APD403 in chemotherapy induced nausea & vomiting published in Supportive Care in Cancer

ACACIA PHARMA ANNOUNCES POSITIVE CLINICAL RESULTS FOR APD403 IN CHEMOTHERAPY INDUCED NAUSEA & VOMITING PUBLISHED IN SUPPORTIVE CARE IN CANCER Cambridge, UK and Indianapolis, US - 12 December 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company") (EURONEXT: ACPH) announces that data and analyses from its positive Phase 2 clinical trial of APD403 (int...

Patrick Treanor appointed President of Relypsa and member of the Executive Committee of Vifor Pharma Group

Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005987/en/ Vifor Pharma Group is pleased to announce the appointment of Patrick Treanor as President of Relypsa on a permanent basis. He is also appointed to the Executive Committee of Vifor Pharma Group with immediate e...

Tuesday 11th December 2018

GARDP, Eisai and Takeda announce partnership in the search for new antibiotics

(Drugs for Neglected Diseases Initiative) The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. (TSE: 4523) ('Eisai') and Takeda Pharmaceutical Company Limited (TSE: 4502) ('Takeda') have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse

Doctors and other caregivers have a new weapon to combat the opioid epidemic. But it’s not a pharmaceutical drug—it’s a mobile app. This week, the FDA cleared “reSET-O,” an app developed by “digital therapeutics” startup Pear Therapeutics, for sale in the U.S. as a treatment for patients recovering from opioid abuse disorder. Doctors can now […]

Rite Aid to Release Third Quarter Results on December 19

Rite Aid Corporation (NYSE: RAD) said today that it will release financial results for its Fiscal 2019 Third Quarter, which ended Dec. 1, 2018, on Wednesday, Dec. 19, 2018. The company will hold an analyst call at 5:00 p.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://www.riteaid.com/corporate/inv...

Walgreens Boots Alliance Announces Transfer of Listing of Debt Securities to Nasdaq

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it will be transferring the securities exchange listing for its 2.125% Senior Notes due 2026, 2.875% Senior Notes due 2020 and 3.600% Senior Notes due 2025 from the New York Stock Exchange to the Nasdaq Bond Exchange effective December 21, 2018 after market close. The debt securities are expected ...

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

Three-Year Outcomes Reveal 37% Mean IOP Decline to 14.3 mmHg, 68% Decline in Mean Number of Topical Ocular Hypotensive Medications and Favorable Safety Profile Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceuti...

Model N Welcomes New Senior Leadership and a New Board Member

New executive leadership to help Model N’s enterprise SaaS business grow and scale Model N, Inc. (NYSE: MODN), the leading provider of cloud revenue management solutions to pharmaceutical, medical device, high-tech manufacturing, and semiconductor companies, today announced new additions to its Board of Directors and leadership team. ...

Intersect ENT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at the Westin St. Francis Hotel in San Francisco, and will present at 4:30 p.m. PT. A replay of the session will be available via the investors section of the company’s websi...

BullFrog AI Announces New Chief Technology Officer

BullFrog AI appoints seasoned executive to lead technology and development vision GAITHERSBURG, Md. (PRWEB) December 11, 2018 BullFrog AI, Inc, a precision pharmaceutical company built around a powerful artificial intelligence (AI) platform, proudly announces the addition of executive Everett Lee as its Chief Technology Officer. Mr. Lee brings nearly 3 decades of technical expertise and continuo...

Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or the “Company”), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced the closing of an underwritten offering for gross proceeds of approximately $10 million, prior to deducting underwriting discounts and co...

5 Top Pharmaceutical News Stories of 2018

What pharmaceutical news stories caught investors' attention in 2018? We run through our five most popular articles. The post 5 Top Pharmaceutical News Stories of 2018 appeared first on Investing News Network.

CloudMinds XI™ Smart Raman Selected as a Finalist for Prism Award; Solution to be Featured in Demos at BiOS Booth 8864 and PW Booth 4087

Prism Award recognizes outstanding examples of innovation and thought leadership in photonics research and development CloudMinds Technology, a developer and operator of cloud robotic solutions announced today that its XI™ Smart Raman has been selected as a finalist in the category of sensors and detectors for the Prism Award. The 2...

Armor Correctional Health Services Promotes Dr. Timothy E. Hughes to Chief Medical Officer

Armor Correctional Health Services is pleased to announce that Timothy E. Hughes, M.D. has been promoted to Chief Medical Officer. Previously, Hughes served as Associate Chief Medical Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005881/en/

Merck's Global Human Health President Schechter Leaving End of Year

NewsAdam Schechter will take on an advisory position as the company reshapes its commercial organization, adding two new executive committee roles.

TEVA Pharmaceutical Industries: Fiebrige Ausschläge!

Beim Blick auf den Chart des Generika-Herstellers TEVA Pharmaceutical Industries wird die extreme Anspannung, die die Anleger in den USA in den letzten Tagen erfasst hat, sehr schnell deutlich. Am ...

New Zealand moves towards legalising medical cannabis

New Zealand’s parliament has passed an amendment to the Misuse of Drugs Act 1975 that will allow terminally ill patients...Read More... The post New Zealand moves towards legalising medical cannabis appeared first on Pharmaceutical Technology.

Smithers Avanza Bioanalytical Services Adds Capabilities With Second Facility on East Coast

Smithers Avanza, a contract research organization supporting the pharmaceutical industry, announced that its Bioanalytical Services division will expand its North American operations with the

MetrioPharm AG: MetrioPharm AG Closes Financing Round of CHF 20 Million

EQS Group-News: MetrioPharm AG / Key word(s): Financing/Capital Increase 11.12.2018 / 16:46 Zurich, December 11, 2018. MetrioPharm AG, a clinical stage pharmaceutical development company, announces that it has successfully completed the current financing round D. MetrioPharm CEO Dr. Wolfgang Brysch: "We are pleased to have completed the current financing round as planned in 2018. Altoget...

Global Hepatitis B Therapeutics Market 2018-2022| Strategic Collaboration Between the Pharmaceutical Companies to Boost Growth| Technavio

The global hepatitis B therapeutics market is expected to post a CAGR of over 2% during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005654/en/


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks